INTRODUCTION
There is renewed interest in the complex role of environmental risk factors in the aetiology of psychosis 1 . Exposure to environmental variation during developmentally sensitive periods is essential for the development of neuronal connectivity, which underlies the functional abilities of the adult human brain including adequate interpretation of perceptual and social stimuli.
Stresses, such as social adversity and drug use, in childhood, adolescence or early adult life may trigger the expression of psychosis, which can progress from subclinical to full-blown psychotic states 2 . Individual differences underlying the organism's response to environmental risk factors, which may be at least partially accounted for by genetic factors, would be decisive in shaping the final expression of psychotic experiences (PEs) or symptoms.
Thus, it is well-established that attenuated PEs occur in some individuals from the general population [3] [4] [5] . In the absence of illness or the need for treatment, these milder forms of psychotic symptoms are referred to as PEs 6 . Furthermore, it has been suggested that clinical and subclinical expression of psychosis share genetic and/or environmental factors in their aetiology 6 . Therefore, the study of the risk factors for PEs would ultimately contribute to the understanding of the aetiology of psychotic disorders.
In this context, childhood adversity constitutes an environmental risk factor that has been related to the expression of clinical and subclinical psychotic symptoms as well as PEs [7] [8] . More recently, cannabis use has been associated consistently with an increased risk of developing psychosis in clinical and non-clinical populations [9] [10] . Furthermore, an interaction effect between childhood adversity and cannabis use has been reported. Studies indicate that joint exposure to these two environmental factors may increase the likelihood of developing psychotic symptoms and/or experiences to a greater extent than the risk expected for each factor working independently [11] [12] [13] [14] . These results are neurobiologically plausible, since both stressful experiences and delta-9-tetrahydrocannabinol (THC, the main psycho-active constituent of cannabis) have been found to increase dopaminergic signalling in the mesolimbic system 15 , which is hypothesized to result in an increased risk of delusions and hallucinations 16 .
However, a recent study of a large sample drawn from the general population reports nonreplication of the interaction effect between cannabis and childhood trauma on the risk of developing psychotic symptoms 17 . Individual differences in neurobiological susceptibility to the impact of childhood abuse and cannabis use might help to explain this failure to replicate. In addition, gene-environment interaction studies have shown that the Val158Met polymorphism of the catechol-O-methyltransferase (COMT) gene moderates i) the association between cannabis use and psychosis [18] [19] and ii) the association between childhood trauma and schizotypal traits 20 . However, to our knowledge, no study to date has investigated whether the impact of the joint effect of exposure to childhood adversity and cannabis use on the subsequent development of PEs partially depends on the COMT-Val158Met polymorphism.
The COMT gene is located in chromosome 22q11 and contains a functional polymorphism (COMT-Val158Met) that results in two common variants of the enzyme (Val and Met) 21 . The 
METHODS

Sample
The sample consisted of 533 individuals who were recruited from the campus of the Jaume I University in Castelló (Spain), as well as from university offices and community technical schools in the metropolitan area of Barcelona (Spain). All the participants were adults (mean age: 22.9 years; SD=5.4) and 45.4% were males. At assessment, 77% of the participants were students.
Exclusion criteria were the presence of any major medical illness affecting brain function, neurological conditions, and a history of head injury. All participants were of Spanish (Caucasian) ancestry, thereby reducing the possibility of confounding genetic differences by population stratification.
Ethical approval was obtained from local research ethics committees. All participants provided written informed consent before inclusion in the study. All procedures were carried out according to the Helsinki Declaration.
Measures
The Community Assessment of Psychic Experiences (CAPE; 24 ) was used to assess positive and negative PEs in the sample. This validated self-report questionnaire measures the lifetime prevalence of PEs on a frequency scale ranging from 'never' to 'nearly always'. Examples of the items that assess the positive and negative dimension are, respectively, 'do you ever feel as if things in magazines or TV were written especially for you?' and 'do you ever feel that you experience few or no emotions at important events?' The CAPE provides a total score per dimension by adding up the scores on the frequency items.
Childhood abuse was assessed by the shortened version of the Childhood Trauma Questionnaire (CTQ; 25 ). This questionnaire consists of 28 items that measure five types of childhood trauma:
emotional abuse, physical abuse, sexual abuse, emotional neglect and physical neglect. In the current study, the subscales that assess abuse were combined to yield a total score of childhood abuse. Neglectful events were discarded, since only abusive events were shown to be associated with PEs in a previous study conducted in this sample 3 . An example of an item on childhood abuse is 'people in my family hit me so hard that it left me with bruises or marks'. The score for each item ranges from 1 to 5 ('never true' -'very often true'), depending on the extent to which individuals agree with the statement. The reliability and validity of the CTQ have been demonstrated 26 .
Cannabis use was assessed with one question regarding the frequency of consumption: 'never', 'once', 'monthly', 'weekly' or 'daily' (this variable was then dichotomized into two categories:
'not exposed to cannabis': never, once; and 'exposed to cannabis': monthly, weekly, daily).
All analyses were corrected by sex, age, schizotypal personality and anxiety levels as in a previous study conducted in this sample 3 . Schizotypal personality was measured with the Schizotypy Personality Questionnaire-Brief (SPQ-B; 27 ). Anxiety as a behavioural trait was assessed using the State-Trait Anxiety Inventory (STAI-T; 28 ).
Laboratory methods
Genomic DNA was extracted from saliva samples using the Collection Kit BuccalAmp DNA extraction kit (Epicentre, ECOGEN, Barcelona, Spain). The SNP rs4680 (Val158Met) of the COMT gene was genotyped using Applied Byosystems (AB) TaqMan technology. The AB assay-on-demand service was used to order the probes. Genotype determinations were performed blind to the clinical condition. Randomized individuals were re-tested for their genotypes in order to confirm the pattern reproducibility.
Statistical Analysis
Multiple linear regressions were conducted using STATA 10.0 for Windows. Separate models Age, sex, schizotypy and trait anxiety were included as covariates in all analyses.
Additional analyses were carried out using logistic regression analysis to investigate whether childhood abuse increased the risk of cannabis use and whether the COMT-Val158Met polymorphism was associated with cannabis use.
The log-likelihood ratio test was used to assess the difference between nested models. In our case, if a significant interaction effect was detected, the log-likelihood ratio test was used to examine whether the addition of the interaction term (either two-way or three-way) significantly improved the model fit compared to the main effects model.
A power analysis was performed using the QUANTO V. ). This parameter can be used to estimate the proportion of variance in the outcome that is accounted for by the predictor. In addition, P<0.05 was considered to indicate statistical significance, but we used a more stringent P-value, based on the Bonferroni correction, for the interactions tested. We conducted three tests (main effects, two-way interaction effects and three-way interaction effects) for two outcomes (positive and negative PEs). Therefore, for a Bonferroni correction on the P-values for interactions, we used P=0.05/6=0.0083 as a threshold for significance.
RESULTS
To obtain the prevalence of PEs, CAPE scores were recoded as 0 (never, sometimes) and 1 (often, almost always). The resulting prevalence rate indicated that 40.7% of the sample often or almost always experienced at least one positive PE. Childhood abuse was also recoded as 0 (never true) and 1 (rarely true, sometimes true, often true and very often true) to calculate the prevalence. In the current sample, 25.5% of the individuals were exposed to at least one abusive event during childhood. In regard to cannabis use, 29.1% of the sample used cannabis monthly, weekly or daily.
All the variables included in the model were available for 419 individuals from the total sample.
In this final sample, the genotype frequencies for the Val158Met polymorphism of the COMT Rates for PEs and childhood trauma in the current sample were in line with previous reports in European and North American samples 6, 25 (further details can be found elsewhere 3 ). In addition, the rate of individuals using cannabis (monthly, weekly or daily) was 29.1%, which is similar to the rates reported in other European countries 30 .
As previously shown in this sample, childhood abuse was associated with both positive and negative PEs 3 . These findings support the role of childhood abuse in the development of PEs in the general population, as reported in previous research 7-8 . Furthermore, the fact that cannabis use did not show a main effect on positive PEs in the current study may be related to the inclusion of childhood abuse in the model. As previous studies have suggested, explorations of the association between cannabis and psychosis need to consider the effects of childhood trauma as an important potential effect modifier 11, 13 . Nevertheless, both childhood abuse and cannabis use were associated independently with negative PEs. This association has also been reported previously 10, 31 .
Additional analyses enabled us to rule out the possibility that childhood abuse increased the likelihood of using cannabis (environment-environment correlation). A gene-environment correlation can also be discarded, since COMT genotypes were not associated with cannabis use.
In accordance with recent evidence, we did not find an interaction between the effect of childhood abuse and cannabis use on PEs 17 . However, we believe that this may be related to the The fact that exposure to both childhood abuse and cannabis was associated with higher scores of positive PEs in Val carriers may be explained by sensitization involving dopaminergic signalling. Evidence from animal studies suggests a possible interaction (exposure to one factor increases sensibility to the effects of the other factor) between stress and THC. Rats living under normal conditions (i.e. access to water and food), that were exposed to THC, showed only minor behavioural changes and no change in dopaminergic transmission 34 . In contrast, under stressful conditions (i.e. isolation and food deprivation), THC administration had marked behavioural consequences and was associated with a significant increase in dopamine uptake 34 .
Similarly, it has been shown in humans that the psychosis-inducing effect of cannabis may be stronger in subjects exposed to early stress 14 . Based on previous findings, our results indicate that variability in the COMT gene confers different neurobiological vulnerability to cannabis use in the risk of developing PEs. In accordance with previous studies, Val carriers are more vulnerable to the psychosis-inducing effects of cannabis than Met/Met individuals 18-19 , but only when exposed to childhood abuse. In line with previous studies indicating that Met carriers were more vulnerable to stress than carriers of the Val/Val genotype 35 , Met carriers were vulnerable to the psychosis-inducing effects of childhood abuse, but only when they did not use cannabis.
Previous evidence indicates that the risk of psychosis did not increase in Met carriers of the COMT gene who used cannabis 18 . However, in the current study, individuals who are homozygous for the Met allele appeared to be able to use cannabis without any increase in risk of developing PEs, but only when they were exposed to childhood abuse. Indeed, cannabis use by Met/Met carriers seems to benefit these individuals. The proposed role of the endocannabinoid system in extinguishing fear-related memories may help to explain these results 36 . In this regard, the use of cannabis for some psychiatric patients has been proposed, to alleviate the stress associated with childhood traumatic experiences 37 . Nevertheless, this result must be interpreted with caution and needs further research and replication.
The results of the present study should be interpreted in the context of its limitations. Firstly, we used a relatively small sample size to detect a three-way interaction. Indeed, power analysis indicated that the present study was slightly underpowered to detect gene-environment interaction effects accounting for at least 1.5% of the outcome. Nevertheless, to prevent false positive results, all analyses were hypothesis-driven, the interaction effects remained significant after correcting for multiple testing and the effect size of the interaction that was detected accounted for 2% of the variance of positive PEs. Post-hoc power analyses revealed that the current sample had 0.85 power to detect the interaction effect. Secondly, the cross-sectional nature of the design does not allow causal inference. Thirdly, childhood abuse was measured retrospectively, which may constitute an inherent source of bias. That said, the Childhood Trauma Questionnaire has been validated and is considered a reliable measure of childhood adversity 26 . Finally, frequency of cannabis use was dichotomously defined in the present study, and other parameters that have been related to the expression of psychotic symptoms such as onset, duration or potency of cannabis consumed 19, 38 , were not specified.
Although the findings of gene-environment interaction studies have been exciting, there is increasing concern about the reliability and contribution of such results to the understanding of complex traits such as PEs. Dismissal of gene-environment interaction studies arises mainly as a result of the failure to replicate 39 . As there are powerful reasons to expect that geneenvironment interaction effects are involved in the aetiology of complex traits and psychiatric disorders 40 , the debate is more focused on the reliability of such findings. To prevent false positive results or statistically significant results that may not represent true insights, the current study was developed with an a priori hypothesis that guided the choice of the gene, the polymorphism and the environmental risk factors that were explored. Moreover, as abovementioned, power analyses are specified and correction for multiple testing was applied.
To our knowledge, this is the first study reporting a gene-environment-environment interaction 
